Total Funding
4
43
Total FundingDebt Financing raised
Growth Score
-3 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
207467
Celsense is a biotechnology company providing magnetic resonance imaging contrast agents.
Paul L. Kornblith: M.D., Chairman of the Board of DirectorsPast Role: Harvard University, faculty member
Charles O'Hanlon: President & CEO
About the Company
Celsense is a privately held biotechnology company offering novel MRI agents that allow scientists and clinicians to monitor the location and quantity of transplanted cells. The company's products have applications in the fields of regenerative medicine, immunotherapy, and the study of inflammation and immune system response.
Celsense is
currently collaborating with leading pharmaceutical and biotechnology organizations and is developing products suitable for human use.
